Proactive Investors
30 Sept 2026, 07:34 UTC · 3h ago
Verdict
Headline leans bullish. We score OBI +0.60 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish · 3 new · 1 priced in
The phase III LANTERN trial of 5,188 patients showed Steriwave cut surgical site infection risk by 40.5% with a 98.2% probability of efficacy.
Newpublished 30 Sep 2026
So whatSuccessful phase III data is the primary catalyst for the mid-2027 FDA filing timeline.
More positive than 99% of claims this week
The company targets a pre-submission meeting with the FDA in Q1 2027 and a New Drug Application filing in mid-2027.
Continue reading
5 related stories
More positive than 78% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Newpublished 30 Sep 2026
More positive than 79% of claims this week
Ondine Biomedical has suspended trading to raise new investment via AIM's Capital Access Window.
Newpublished 30 Sep 2026
So whatThe move follows a cash drop to C$5.3 million, making immediate financing essential to avoid insolvency.
More negative than 76% of claims this week
Six-month revenue to June 30 rose 23% to C$1.25 million, while operating loss widened to C$15.9 million.
Priced inreferencing interims to 30 June
More negative than 62% of claims this week
Which stocks this story touches
More positive than 78% of ticker scores this week
The company reported successful Phase III trial results for Steriwave and revenue growth, despite current operating losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
5h ago
—
No price for OBI right now — the quote feed didn't answer.
OBI chart →
